ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes

ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes

<p><strong>Objectives</strong></p> <p>The use of aspirin for the secondary prevention of cardiovascular disease (CVD) is firmly established, and the proportional reductions in heart attacks and strokes appear to be similar in people with and without diabetes. Uncertaint...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Bowman, L, Mafham, M, Stevens, W, Haynes, R, Buck, G, Collins, R, Armitage, J, ASCEND Study Collaborative Group
التنسيق:	Journal article
منشور في:	Elsevier 2017

مواد مشابهة

Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial
حسب: Parish, S, وآخرون
منشور في: (2022)

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
حسب: Emily L. Sammons, وآخرون
منشور في: (2024-11-01)

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
حسب: Sarah Parish, وآخرون
منشور في: (2023-03-01)

ASCEND-Eye: effects of aspirin on diabetic retinopathy
حسب: Sammons, E, وآخرون
منشور في: (2024)

ASCEND-Eye: effects of omega-3 fatty acids on diabetic retinopathy
حسب: Sammons, E, وآخرون
منشور في: (2023)

ASCEND-eye: rationale, design and baseline characteristics for a sub-study of the ASCEND randomized trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration
حسب: Sammons, E, وآخرون
منشور في: (2023)

ASCEND-Eye: Rationale, design and baseline characteristics for a sub-study of the ASCEND randomised trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration
حسب: Emily Sammons, وآخرون
منشور في: (2023-10-01)

Effects of aspirin for primary prevention in persons with diabetes mellitus
حسب: Bowman, L, وآخرون
منشور في: (2018)

Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND).
حسب: Aung, T, وآخرون
منشور في: (2016)

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
حسب: Parish, S, وآخرون
منشور في: (2023)

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
حسب: Sammons, EL, وآخرون
منشور في: (2024)

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
حسب: Sammons, EL, وآخرون
منشور في: (2024)

Effects of omega−3 fatty acid supplements on arrhythmias
حسب: Parish, S, وآخرون
منشور في: (2020)

Aspirin for primary prevention of vascular disease in people with diabetes.
حسب: Haynes, R, وآخرون
منشور في: (2009)

Thromboxane biosynthesis and future events in diabetes: the ASCEND trial
حسب: Petrucci, G, وآخرون
منشور في: (2024)

Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes
حسب: Praveen Patel, وآخرون
منشور في: (2025-02-01)

Streamlined mail-based methods for large randomised trials: lessons learnt from the ASCEND study
حسب: Mafham, MM, وآخرون
منشور في: (2019)

The ASCEND-Eye study: effect(s) of aspirin and omega-3 fatty acids on eye disease
حسب: Sammons, E
منشور في: (2023)

Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial
حسب: Aung, T, وآخرون
منشور في: (2017)

Effects of n-3 fatty acid supplements in diabetes mellitus
حسب: Ascend Study Collaborative Group, وآخرون
منشور في: (2018)

Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial
حسب: Rocca, B, وآخرون
منشور في: (2020)

Comparison of routinely collected data with clinical trial adjudicated direct follow-up: post-hoc analyses of serious cardiovascular events from the United Kingdom-based ASCEND randomized trial
حسب: Harper, C, وآخرون
منشور في: (2021)

Comparison of the accuracy and completeness of records of serious vascular events in routinely collected data vs clinical trial–adjudicated direct follow-up data in the UK: secondary analysis of the ascend randomized clinical trial
حسب: Harper, C, وآخرون
منشور في: (2021)

Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial.
حسب: Andrea K Viecelli, وآخرون
منشور في: (2019-01-01)

Performance of the UKPDS Outcomes Model 2 in a contemporary UK type 2 diabetes trial cohort
حسب: Keng, MJ, وآخرون
منشور في: (2021)

Comparison of effectiveness of low-dose aspirin versus omega-3 fatty acids as adjuvants to nonsurgical periodontal therapy in Type II diabetic patients with chronic periodontitis
حسب: Prathyusha Rampally, وآخرون
منشور في: (2019-01-01)

Granulation tissue enriched by aspirin and omega-3 fatty acids in healing experimental periodontal lesion
حسب: Filip Hromcik, وآخرون
منشور في: (2021-06-01)

Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.
حسب: Hartweg, J, وآخرون
منشور في: (2008)

Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.
حسب: Hartweg, J, وآخرون
منشور في: (2008)

Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia.
حسب: Eugene Han, وآخرون
منشور في: (2016-01-01)

Synergistic effects of omega-3 polyunsaturated fatty acids and aspirin in the clinical practice – a narrative review
حسب: Zajac-Grabiec Anna, وآخرون
منشور في: (2024-03-01)

Omega-3 fatty acids, insulin resistance and type 2 diabetes
حسب: Leila Azadbakht, وآخرون
منشور في: (2011-01-01)

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
حسب: Price, H, وآخرون
منشور في: (2009)

Aspirin for primary prevention of cardiovascular disease in diabetes
حسب: Ying Xing, وآخرون
منشور في: (2019-07-01)

N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study.
حسب: Emberson, JR, وآخرون
منشور في: (2007)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
حسب: Cull, C, وآخرون
منشور في: (2004)

Prescription omega-3 fatty acid products: considerations for patients with diabetes mellitus
حسب: Tajuddin N, وآخرون
منشور في: (2016-04-01)

Omega-3 fatty acids coordinate glucose and lipid metabolism in diabetic patients
حسب: Pasquale Mone, وآخرون
منشور في: (2022-03-01)

The relationship of dietary omega-3 fatty acid and omega-6 to omega-3 ratio intake and likelihood of type 2 diabetes in a cross-sectional study
حسب: Ebrahim Shakiba, وآخرون
منشور في: (2024-11-01)

Benefit of heparin plus aspirin vs aspirin alone in unstable angina.
حسب: Collins, R, وآخرون
منشور في: (1996)